Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
ALLN-177, oral enzyme therapy for hyperoxaluria.
Journal: International urology and nephrology
Published: November 08, 2018
A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.
Journal: American journal of nephrology
Published: February 20, 2016
Showing 1-2 of 2
Last Updated: 09/26/2026